The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires
multimodality imaging. Transthoracic echocardiogram (TTE) remains the first-line imaging …

Abstract Aim The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the
Management of Hypertrophic Cardiomyopathy” provides recommendations to guide …

Background The prognostic utility of cardiovascular magnetic resonance imaging, including
strain analysis and tissue characterization, has not been comprehensively investigated in …

Imaging cardiac hypertrophy in hypertrophic cardiomyopathy a... : Current Opinion in
Cardiology Imaging cardiac hypertrophy in hypertrophic cardiomyopathy and its differential …

Background: To explore the value of a novel ventricular-vascular coupling index (VVI)
system in relation to age, gender and body mass index (BMI). Methods: A total of 239 …

Impaired left ventricular global longitudinal strain (GLS) and coronary artery disease (CAD)
each confer adverse prognosis in hypertrophic cardiomyopathy (HCM). Despite their …

Purpose To investigate whether the peak early filling rate normalized to the filling volume
(PEFR/FV) estimated from four-dimensional (4D) flow cardiac MRI may be used to assess …

Medical science is dedicated to shedding light on the ordered sequence of events that may
link the cause of generic disorders to their subsequent clinical manifestations. One prime …

Despite changes in the distribution of practice-and hospital-based cardiovascular imaging,
the total numbers of echocardiograms and cardiac magnetic resonance (CMR) studies …

Dieser Artikel beschreibt den klinischen Nutzen der kardiovaskulären
Magnetresonanztomografie (Kardio-MRT) bei Patienten mit Kardiomyopathien. Die Kardio …